Building on a long history of leadership in allergy and asthma research #McMasterU, the Schroeder Allergy and Immunology Research Institute has made groundbreaking discoveries in the field of allergy research @MacImmunology#allergy https://t.co/Pf8G8EGUYl
A huge congratulations to our very own @jfekoenig for his @MSU_McMaster Teaching Award! Keep up the amazing work! #brighterworld@machealthsci https://t.co/5Ht9AvWgcu
A huge congratulations to Vitoria Olyntho, recipient of the BHSc Summer 2022 Research Scholarship! She will be completing her research with the @Jordana_Lab. We look forward to the amazing research you will produce! @machealthsci
@liza_allergist@FrontAllergy but it’s unclear whether this would impart sustained protection, or what we refer to as a “disease-transformative” therapy.
@liza_allergist@FrontAllergy Work from H Oettgen and others suggests that IgG4 inhibits MC/basophil activation through FcyRIIb and, perhaps, through sequestering allergen prior to its engagement with receptor-bound IgE. So IgG4 MAb treatment may ameliorate adverse events during OIT, similar to omalizumab...
Here, we discuss the immunobiology which underlies the persistence of IgE memory to food allergens, current/experimental treatments, and our perspective on future avenues to establish “disease-transformative” therapies. 3/
This review highlights that SLIT is a safe and effective treatment that considerably reduces symptoms and medication requirements in AR and improves quality of life. ▶️ https://t.co/avXTZUft92
Excellent presentation from first year MSc student in the @Jordana_Lab! 👏 Emily’s work focuses on investigating the role of CD4+ T cells in allergic priming!
We are honoured to have hosted Dr. Marc Jenkins as a keynote speaker at this years Perey Symposium! Dr. Jenkins gave a fantastic talk on his latest work identifying antigen specific CD4+T cells.